On the other hand, the hypothesis of an inflammatory syndrome accompanying fungal infections, especially after the acute phase, led some investigators to the hypothesis that blocking the IL-6 signaling pathway, among others, could interrupt an exaggerated immune response, inducing favorable outcomes [7]. Here, IL6 is linked to fungal infectious disease.